Self-Help Cognitive Processing Therapy (CPT) for Women Veterans with PTSD
This study is looking at new ways to help women veterans who have Posttraumatic Stress Disorder (PTSD) and depression. It tests two approaches: a self-help version of Cognitive Processing Therapy (CPT), which is a type of talk therapy proven to help with PTSD, and a combination of self-help CPT with support from the Women Veterans Network (WoVeN). You might be able to join if you are a woman veteran, aged 18 or older, and have a PTSD diagnosis. The study will measure how much your PTSD symptoms improve to see if these approaches are helpful. The current recruitment status is unclear, but the study plans to enroll 100 participants.
- Study design
- This is a randomized controlled study with three groups, involving 100 women veterans. Participants will be randomly assigned to receive self-help CPT, self-help CPT plus WoVeN support, or standard care.
- What's involved
- You would complete treatments within 10 weeks, and have three main assessments (at the start, after 10 weeks, and 3 months later) that take about 2.5 hours each. You would also complete weekly surveys to track your progress.
- Compensation
- Not stated in the trial record.
- Follow-up
- Your PTSD symptoms will be checked at 10 weeks (after treatment) and again at 28 weeks (about 3 months after treatment).
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Self-Help Cognitive Processing Therapy (CPT)/Women Veterans Network (WoVeN) Study
At a glance
Conditions
Where it's being run
1 sites across 1 statesStudy leadership
- Tara E Galovski, PhD · PRINCIPAL_INVESTIGATOR · BUCA School of Medicine, Psychiatry and VA Medical Center
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Clinician assessed PTSD SymptomsPre intervention- baseline, Post intervention- 10 weeks, Follow-up- 28 weeks
This outcome will be assessed with the Clinician-Administered PTSD Scale for the Diagnostic and Statistical Manual of Mental Illnesses (DSM-5) (CAPS-5). It obtains information about frequency and intensity for the 20 PTSD symptoms using a 5-point ordinal scale from 0 (absent) to 4 (extreme/incapacitating), based on the patient's frequency and intensity of the symptom. The final score is a total severity score that can range from 0 to 80 with higher scores indicating more severe PTSD symptoms.